D. E. Shaw & Co., Inc. Insulet Corp Put Options Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $1.61 Million - $2.07 Million	-10,000 Reduced 23.15%	33,200 $6.7 Million
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $1.65 Million - $2.11 Million	10,100 Added 30.51%	43,200 $7.4 Million
Q4 2023 Feb 14, 2024	SELL	$127.77 - $221.42 $12,777 - $22,142	-100 Reduced 0.3%	33,100 $7.18 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $5.14 Million - $9.66 Million	33,200 New	33,200 $5.3 Million
Q1 2021 May 17, 2021	BUY	$235.95 - $293.05 $1.23 Million - $1.52 Million	5,200 Added 108.33%	10,000 $2.61 Million
Q4 2019 Feb 14, 2020	BUY	$144.81 - $186.0 $695,088 - $892,800	4,800 New	4,800 $822,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.